Literature DB >> 19155770

Is dual therapy with raltegravir and protease inhibitors a feasible option in rescue strategy in HIV-1 infection?

Amedeo Ferdinando Capetti, Stefania Piconi, Simona Landonio, Giuliano Rizzardini, Carlo Federico Perno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19155770     DOI： 10.1097/QAI.0b013e31818c7e8e

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

1.  Darunavir-based dual therapy of treatment-experienced HIV-infected patients: analysis from a national multicenter database.

Authors:  Gaetana Sterrantino; Mauro Zaccarelli; Antonio Di Biagio; Maria Luisa Biondi; Andrea Antinori; Giovanni Penco
Journal:  Infection       Date:  2015-03-28       Impact factor: 3.553

Review 2.  Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.

Authors:  Babafemi Taiwo; Robert L Murphy; Christine Katlama
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

3.  96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience.

Authors:  Amedeo Capetti; Simona Landonio; Paola Meraviglia; Antonio Di Biagio; Sergio Lo Caputo; Gaetana Sterrantino; Adriana Ammassari; Barbara Menzaghi; Marco Franzetti; Giuseppe Vittorio De Socio; Giovanni Pellicanò; Elena Mazzotta; Alessandro Soria; Marianna Meschiari; Michele Trezzi; Lolita Sasset; Benedetto Maurizio Celesia; Patrizia Zucchi; Sara Melzi; Elena Ricci; Giuliano Rizzardini
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

4.  Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study.

Authors:  Alessandra Latini; Massimiliano Fabbiani; Vanni Borghi; Gaetana Sterrantino; Alberto Giannetti; Patrizia Lorenzini; Laura Loiacono; Adriana Ammassari; Rita Bellagamba; Manuela Colafigli; Gabriella D'Ettorre; Simona Di Giambenedetto; Andrea Antinori; Mauro Zaccarelli
Journal:  BMC Infect Dis       Date:  2016-08-11       Impact factor: 3.090

Review 5.  Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients.

Authors:  Jean-Guy Baril; Jonathan B Angel; M John Gill; Joseph Gathe; Pedro Cahn; Jean van Wyk; Sharon Walmsley
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

6.  High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil.

Authors:  José Ernesto Vidal; Alice Tung Wan Song; Maria Laura Matos; Daniel Bartmann; Guilherme Dos Anjos; Érique José Peixoto de Miranda; Ângela Carvalho Freitas; Mirian de Freitas Dalben; Claudinei Santana; Aluísio Cotrim Segurado; Cláudia Cortese Barreto; Adrián Vladimir Hernández
Journal:  Braz J Infect Dis       Date:  2013-01-05       Impact factor: 3.257
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.